Among the many 167 million individuals with employer-sponsored insurance coverage in 2022, 3.4 million used at the very least one of many first 10 medicine recognized for Medicare value negotiations, based on a brand new evaluation. Probably the most used drug for individuals with employer-sponsored medical health insurance was Jardiance, a drug used to deal with diabetes and coronary heart failure, which was taken by greater than 911,000 enrollees.
The analysis makes use of the Merative MarketScan 2022 industrial claims to estimate the variety of enrollees within the employer-sponsored insurance coverage market who use a number of of the ten medicine chosen for Medicare Half D value negotiations.
The complete evaluation and different knowledge on well being prices can be found on the Peterson-KFF Health System Tracker, a web-based data hub devoted to monitoring and assessing the efficiency of the U.S. well being system.
